UniCredit, Swedbank, Groupe BPCE and Íslandsbanki contributed to an $11.8m round that took the banking software provider’s total funding past $55m.
Author: Jordan Williams
Avanti gets corporate aid to raise $37m
Coinbase, Banca del Ceresio, ECMC and SIG were among the participants in a series A round that took the digital asset banking startup’s total funding to $44m.
Zymergen zooms to IPO stage
Hanwha and SoftBank could exit the advanced biomaterials developer in the offering, which will follow more than $870m in funding.
Ginger snaps up $100m in series E
The Cigna and Kaiser Permanente-backed mental healthcare app developer took its total funding to $220m in a round valuing it at about $1bn.
Cutover collects $35m in series B round
The Barclays-backed work management platform developer is looking to expand into new verticals after securing series B funding.
Group 11 invites in insurers
Migdal Insurance, Harel Group, Menora Mivtachim Insurance and Hachshara Insurance helped the financial technology-focused investor reach a $120m first close of its latest fund.
Feedzai to fight financial crime with $200m
Citi’s strategic investment vehicle helped fill out a series D round valuing the risk management software developer above $1bn.
Brii Biosciences gets $155m boost
The WuXi AppTec-backed infectious disease therapeutics developer has closed a series C round featuring various investment managers and Singapore’s sovereign wealth fund.
AbSci absorbs $125m
New and existing investors provided crossover financing for the synthetic biology technology developer, which already counts Merck & Co, AGC Asahi Glass and JSR Life Sciences as investors.
Recursion takes steps toward $100m IPO
Bayer could exit the drug discovery technology developer should it complete an initial public offering on the Nasdaq Global Select Market.
Helsinn hails 3B Future Health Fund II
Helsinn is co-anchoring the second 3B Future Health Fund, which will target oncology and rare disease therapeutics startups as it seeks a $118m close.
UiPath closes Cloud Elements acquisition
API integration platform developer Cloud Elements has been acquired after raising more than $46m from investors including American Express Ventures.
Evidation Health leverages corporates to raise $153m
The health data analytics provider’s series E round was co-led by Kaiser Permanente Group Trust at a $1bn valuation and also featured McKesson Ventures.
Aura Biosciences shines with $80m
Lundbeckfonden Ventures and Chiesi Ventures have once again invested in the ocular oncology therapy developer, which has now raised $191m in total.